The LTEN Board of Directors has elected its newest member, Mani Chidambaram of Sanofi, beginning immediately. Mani is rejoining the board, where he previously served as a member from 2007 to 2009.
Mani is head of Commercial Learning & Development, Vaccines, for Sanofi US. He’s spent more than 30 years in life sciences training, with companies including Bristol Myers Squibb, Schwarz Pharma, Allergan and Syneos Health. Mani has been a part of LTEN since 1996 and was named an Outstanding Member in 2005. Mani joined the LTEN Advisory Council in 2022 and has been active on several LTEN committees.
“It’s an honor to be returning to the LTEN Board of Directors,” Mani said. “In my nearly 30 years with LTEN, I’ve been fortunate enough to help support our network as it has grown in size and scope. I’ve had the chance to contribute as a member, an Advisory Council member and now again as a director. I look forward to helping as we continue to provide support, solutions and opportunities to our members.”
